Clover Health to Report Second Quarter 2022 Financial Results on August 8, 2022

11 Jul 2022
www.biospace.com
Financial Statement
FRANKLIN, Tenn., July 11, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that it will report second quarter 2022 financial results after market close on Monday, August 8, 2022. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company’s business and financial results. Second Quarter Conference Call and Webcast Details: What: Clover Health Second Quarter 2022 Earnings Conference Call When: Monday, August 8, 2022, at 5:00 p.m. ET Dial In: To access the call via telephone please dial 800-891-3840 (for U.S. callers) or 785-424-1249 (for callers outside the U.S.) and enter the conference ID CLOVQ222 Webcast: A live and archived webcast of the conference call will be accessible from the Investor Relations section of the Company’s website at for 12 months About Clover Health: Clover Health (Nasdaq: CLOV) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is underpinned by our proprietary software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes. We operate two distinct lines of business: Insurance and Non-Insurance. Through our Insurance line of business, we provide PPO and HMO plans to Medicare Advantage members in several states. Our Non-Insurance line of business offers a variety of programs aimed at reducing expenditures and enhancing the quality of care for patients enrolled in fee-for-service Medicare. Clover’s corporate headquarters are in Franklin, Tenn. Press Contact: Andrew Still-Baxter press@cloverhealth.com Investor Relations Contacts: Ryan Schmidt investors@cloverhealth.com Steve Halper shalper@lifesciadvisors.com
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.